Holding(s) in Company

Dechra Pharmaceuticals PLC

11 July 2023

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

06-Jul-2023

6. Date on which Issuer notified

10-Jul-2023

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	3.779552	4.189167	7.968719	9075110
Position of previous notification (if applicable)	4.136226	4.198631	8.334857

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		4304310		3.779552
Sub Total 8.A	4304310		3.779552%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	31/07/2023	31/07/2023	Cash	39012	0.034256
Cash-settled Equity Swap	27/09/2023	27/09/2023	Cash	1257275	1.103995
Cash-settled Equity Swap	03/10/2023	03/10/2023	Cash	17	0.000015
Cash-settled Equity Swap	11/10/2023	11/10/2023	Cash	1259141	1.105633
Cash-settled Equity Swap	24/11/2023	24/11/2023	Cash	1189996	1.044918
Cash-settled Equity Swap	28/11/2023	28/11/2023	Cash	757667	0.665296
Cash-settled Equity Swap	16/01/2024	16/01/2024	Cash	2728	0.002395
Cash-settled Equity Swap	20/02/2024	20/02/2024	Cash	6220	0.005462
Cash-settled Equity Swap	04/03/2024	04/03/2024	Cash	5090	0.004469
Cash-settled Equity Swap	03/04/2024	03/04/2024	Cash	49408	0.043384
Cash-settled Equity Swap	02/05/2024	02/05/2024	Cash	71	0.000062
Cash-settled Equity Swap	17/05/2024	17/05/2024	Cash	57	0.000050
Cash-settled Equity Swap	04/06/2024	04/06/2024	Cash	3452	0.003031
Cash-settled Equity Swap	19/06/2024	19/06/2024	Cash	1804	0.001584
Cash-settled Equity Swap	27/06/2024	27/06/2024	Cash	3172	0.002785
Cash-settled Equity Swap	02/07/2024	02/07/2024	Cash	4515	0.003965
Cash-settled Equity Swap	23/07/2024	23/07/2024	Cash	344	0.000302
Cash-settled Equity Swap	31/07/2024	31/07/2024	Cash	3221	0.002828
Cash-settled Equity Swap	02/08/2024	02/08/2024	Cash	97732	0.085817
Cash-settled Equity Swap	03/09/2024	03/09/2024	Cash	343	0.000301
Cash-settled Equity Swap	11/07/2025	11/07/2025	Cash	728	0.000639
Cash-settled Equity Swap	16/01/2026	16/01/2026	Cash	420	0.000369
Cash-settled Equity Swap	28/04/2026	28/04/2026	Cash	51774	0.045462
Cash-settled Equity Swap	18/06/2027	18/06/2027	Cash	16803	0.014754
Cash-settled Equity Swap	05/05/2028	05/05/2028	Cash	7080	0.006217
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	4306	0.003781
Cash-settled Equity Swap	24/06/2030	24/06/2030	Cash	133	0.000117
Cash-settled Equity Swap	28/06/2030	28/06/2030	Cash	8291	0.007280
Sub Total 8.B2				4770800	4.189167%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	3.770510	4.189170	7.959680%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.
JPMorgan Chase Holdings LLC (100%)
J.P. Morgan Broker-Dealer Holdings Inc. (100%)
J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)

12. Date of Completion

10-Jul-2023

13. Place Of Completion

London

 

END